NZSE - Delayed Quote • NZD Ryman Healthcare Limited (RYM.NZ) Follow Compare 4.4000 -0.0900 (-2.00%) At close: January 17 at 5:00:19 PM GMT+13 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Three Companies That May Be Priced Below Their Estimated Worth In December 2024 As global markets navigate a period of cautious optimism marked by recent rate cuts and economic uncertainties, investors are keenly observing the implications of these developments on stock valuations. Amidst this backdrop, identifying stocks that may be undervalued could present opportunities for those looking to capitalize on potential market inefficiencies. Understanding the fundamentals and intrinsic value of companies can be crucial in recognizing stocks that might not yet reflect their... Undervalued Small Caps With Insider Buying Opportunities For December 2024 As global markets navigate a period of economic uncertainty, smaller-cap stocks have faced challenges, with the Russell 2000 Index underperforming larger peers like the S&P 500. Amidst expectations for a Federal Reserve rate cut and signs of a cooling labor market, investors are closely watching small-cap opportunities that may offer potential value in this shifting landscape. In such an environment, identifying stocks with strong fundamentals and strategic insider activity can be crucial for... Ryman Healthcare Ltd (RHCGF) (H1 2025) Earnings Call Highlights: Navigating Challenges with ... Despite financial setbacks, Ryman Healthcare Ltd (RHCGF) focuses on strategic initiatives and operational improvements to drive future growth. 3 Stocks Estimated To Be Trading At Discounts Of Up To 41.8% As global markets experience broad-based gains and U.S. indexes approach record highs, investors are navigating a landscape marked by geopolitical tensions and economic uncertainties. Amidst these conditions, identifying undervalued stocks can be a strategic move for those looking to capitalize on potential market inefficiencies. Owning 49% shares,institutional owners seem interested in Ryman Healthcare Limited (NZSE:RYM), Key Insights Significantly high institutional ownership implies Ryman Healthcare's stock price is sensitive to their... NRW Holdings And 2 Other Top Undervalued Small Caps With Insider Actions In The Region In recent weeks, global markets have displayed a notable shift towards small-cap and value shares, with the Russell 2000 Index reflecting a positive trajectory. This trend underscores an environment where discerning investors might find significant opportunities among undervalued small caps, such as NRW Holdings, which are poised to potentially benefit from current market dynamics. Exploring Three Undervalued Small Caps With Insider Action In The Region As global markets display mixed reactions with a notable pivot towards small-cap and value shares, investors are keenly observing these segments for potential opportunities. In such an environment, identifying undervalued small-cap stocks with significant insider action can offer intriguing prospects for discerning investors looking to capitalize on market shifts and underlying economic signals. Exploring Undervalued Small Caps With Insider Actions In July 2024 As of July 2024, global markets are exhibiting a notable shift with investors increasingly turning their focus towards value and small-cap stocks, as evidenced by the Russell indexes which highlight a significant divergence in performance favoring these sectors. This pivot is occurring amidst mixed economic signals and ongoing geopolitical tensions, particularly between China and the U.S., influencing market dynamics. In this context, identifying undervalued small-cap stocks becomes... Ryman Healthcare Limited's (NZSE:RYM) Intrinsic Value Is Potentially 80% Above Its Share Price Key Insights Ryman Healthcare's estimated fair value is NZ$7.47 based on 2 Stage Free Cash Flow to Equity Ryman... The past three years for Ryman Healthcare (NZSE:RYM) investors has not been profitable If you love investing in stocks you're bound to buy some losers. But the long term shareholders of Ryman Healthcare... Ryman Healthcare Full Year 2024 Earnings: EPS: NZ$0.007 (vs NZ$0.50 in FY 2023) Ryman Healthcare ( NZSE:RYM ) Full Year 2024 Results Key Financial Results Revenue: NZ$689.9m (up 21% from FY 2023... Investors Could Be Concerned With Ryman Healthcare's (NZSE:RYM) Returns On Capital Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key... Ryman Healthcare Insiders Placed Bullish Bets Worth NZ$2.56m Over the last year, a good number of insiders have significantly increased their holdings in Ryman Healthcare Limited... Institutions own 38% of Ryman Healthcare Limited (NZSE:RYM) shares but individual investors control 57% of the company Key Insights Ryman Healthcare's significant individual investors ownership suggests that the key decisions are... Performance Overview Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is S&P/NZX 50 INDEX GROSS ( GROSS Return RYM.NZ S&P/NZX 50 INDEX GROSS ( GROSS YTD -6.58% +0.15% 1-Year -26.67% +11.96% 3-Year -59.28% +2.53%